Skip to NavigationSkip to content

Chris Kilbee appointed Group director of UBM Pharma Portfolio

Published on: 10/01/14

Amsterdam: CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group director of the UBM Pharma Portfolio. 

Kilbee will be responsible for driving the firm’s portfolio globally including an increased emphasis on digital and content.

Central to the role is responsibility for the strategic development and delivery of its event brands CPhI, ICSE, Inno-Pack and P-MEC, that take place in Europe and worldwide.

An experienced business leader who has worked across a number of different parts of UBM, Kilbee was most recently running a media and events business based in London.


Kilbee said: "I am delighted to be taking on this position and overseeing the Pharma portfolio at UBM Live. It is our vision to widen CPhI's pharma portfolio across new and diverse geographies and platforms where we see opportunities emerging, delivering new services that help to connect the pharma community."

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches